Cargando…

Anti-cancer effects of ginsenoside CK on acute myeloid leukemia in vitro and in vivo

OBJECTIVES: Acute myeloid leukemia (AML) is a malignant disease characterized by clonal proliferation of myeloid cells, and its treatment continues to be a challenge due to high morbidity and mortality. Ginsenoside compound K, a major active metabolite of the protopanaxadiol-type ginsenosides, exhib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Yuzhu, Meng, Xiangru, Sun, Kaiju, Zhao, Mingyue, Liu, Xin, Yang, Tongtong, Zhang, Zhe, Su, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761710/ https://www.ncbi.nlm.nih.gov/pubmed/36544827 http://dx.doi.org/10.1016/j.heliyon.2022.e12106

Ejemplares similares

Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells
por: Chen, Yan, et al.
Publicado: (2013)

Mechanistic Basis for In Vivo Therapeutic Efficacy of CK2 Inhibitor CX-4945 in Acute Myeloid Leukemia
por: Klink, Morgann, et al.
Publicado: (2021)

Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m(6)A signaling
por: Sun, Kaiju, et al.
Publicado: (2021)

Production of Minor Ginsenoside CK from Major Ginsenosides by Biotransformation and Its Advances in Targeted Delivery to Tumor Tissues Using Nanoformulations
por: Murugesan, Mohanapriya, et al.
Publicado: (2022)

Ginsenoside Rc Promotes Bone Formation in Ovariectomy-Induced Osteoporosis In Vivo and Osteogenic Differentiation In Vitro
por: Yang, Nan, et al.
Publicado: (2022)

Icaritin Shows Potent Anti-Leukemia Activity on Chronic Myeloid Leukemia In Vitro and In Vivo by Regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT Signalings
por: Zhu, Jian feng, et al.
Publicado: (2011)

Biomimetic doxorubicin/ginsenoside co-loading nanosystem for chemoimmunotherapy of acute myeloid leukemia
por: Chen, Mo, et al.
Publicado: (2022)

Co-culture Systems of Drug-Treated Acute Myeloid Leukemia Cells and T Cells for In Vitro and In Vivo Study
por: Li, Yangchan, et al.
Publicado: (2020)

Ginsenoside CK Inhibits TGF-β-Induced Epithelial-Mesenchymal Transition in A549 Cell via SIRT1
por: Sun, Mingyang, et al.
Publicado: (2021)

Ginsenoside Rb1 Reduces Isoproterenol-Induced Cardiomyocytes Apoptosis In Vitro and In Vivo
por: Wang, Xiu-feng, et al.
Publicado: (2013)

Casein Kinase 2 (CK2): A Possible Therapeutic Target in Acute Myeloid Leukemia
por: Bruserud, Øystein, et al.
Publicado: (2023)

In vitro and in vivo anti-leukemic activity of the peptidase-potentiated alkylator melflufen in acute myeloid leukemia
por: Strese, Sara, et al.
Publicado: (2016)

Inhibitory Effect of pH-Responsive Nanogel Encapsulating Ginsenoside CK against Lung Cancer
por: Xue, Ziyang, et al.
Publicado: (2021)

Ginsenoside CK Inhibits the Early Stage of Adipogenesis via the AMPK, MAPK, and AKT Signaling Pathways
por: Oh, Jung-Mi, et al.
Publicado: (2022)

Synergistic effect of ginsenoside Rg3 with verapamil on the modulation of multidrug resistance in human acute myeloid leukemia cells
por: KIM, SUNG SU, et al.
Publicado: (2014)

The ways for ginsenoside Rh2 to fight against cancer: the molecular evidences in vitro and in vivo.
por: Hu, Qi-rui, et al.
Publicado: (2023)

Functional Regulation of Ginsenosides on Myeloid Immunosuppressive Cells in the Tumor Microenvironment
por: Zhang, Yanfei, et al.
Publicado: (2019)

The in Vitro Structure-Related Anti-Cancer Activity of Ginsenosides and Their Derivatives
por: Dong, Hang, et al.
Publicado: (2011)

Bioconversion variation of ginsenoside CK mediated by human gut microbiota from healthy volunteers and colorectal cancer patients
por: Guo, Yin-Ping, et al.
Publicado: (2021)

Production of Gypenoside XVII from Ginsenoside Rb1 by Enzymatic Transformation and Their Anti-Inflammatory Activity In Vitro and In Vivo
por: Zhou, Kailu, et al.
Publicado: (2023)

Aprepitant Sensitizes Acute Myeloid Leukemia Cells to the Cytotoxic Effects of Cytosine Arabinoside in vitro and in vivo
por: Wu, Hongzhang, et al.
Publicado: (2020)

CK2 as anti-stress factor
por: Watabe, Masahiko, et al.
Publicado: (2012)

Therapeutic targeting of CK2 in acute and chronic leukemias
por: Buontempo, F, et al.
Publicado: (2018)

ABL Genomic Editing Sufficiently Abolishes Oncogenesis of Human Chronic Myeloid Leukemia Cells In Vitro and In Vivo
por: Chen, Shu-Huey, et al.
Publicado: (2020)

Ginsenosides Rg1 and CK Control Temozolomide Resistance in Glioblastoma Cells by Modulating Cholesterol Efflux and Lipid Raft Distribution
por: Qiu, Runze, et al.
Publicado: (2022)

Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300
por: Rosales, Mauro, et al.
Publicado: (2021)

Comparing the Diagnostic Outcomes of Staining Various Breast Lesions with Either Anti-CK 5/6 or Anti-CK 5
por: Gudi, Mihir A, et al.
Publicado: (2019)

Neuroprotective Effect of the Ginsenoside Rg1 on Cerebral Ischemic Injury In Vivo and In Vitro Is Mediated by PPARγ-Regulated Antioxidative and Anti-Inflammatory Pathways
por: Li, Yang, et al.
Publicado: (2017)

Dendrogenin A Synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo
por: Serhan, Nizar, et al.
Publicado: (2020)

Myeloid Cell CK2 Regulates Inflammation and Resistance to Bacterial Infection
por: Larson, Sandy R., et al.
Publicado: (2020)

Macro-CK and CK-BB Contributing to Sham CK-MB Elevation
por: Wada, Yuki, et al.
Publicado: (2017)

Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects
por: Ferreira, A K, et al.
Publicado: (2013)

Anti-Tumor Effects of BDH1 in Acute Myeloid Leukemia
por: Han, Fei, et al.
Publicado: (2021)

Regulatory network of ginsenoside biosynthesis under Ro stress in the hairy roots of Panax ginseng revealed by RNA sequencing
por: Meng, Xiangru, et al.
Publicado: (2022)

Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study
por: Zheng, Qi, et al.
Publicado: (2021)

Brain Transport Profiles of Ginsenoside Rb(1) by Glucose Transporter 1: In Vitro and in Vivo
por: Wang, Yu-Zhu, et al.
Publicado: (2018)

Predictive value of integrin α7 for acute myeloid leukemia risk and its correlation with prognosis in acute myeloid leukemia patients
por: Zeng, Mingyue, et al.
Publicado: (2019)

Detection of anti-Toxoplasma gondii antibodies in chronic myeloid leukemia and acute myeloid leukemia patients
por: Gharavi, Mohammad Javad, et al.
Publicado: (2017)

Corrigendum: Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study
por: Zheng, Qi, et al.
Publicado: (2022)

Synergistic anti-liver cancer effects of curcumin and total ginsenosides
por: Deng, Zhe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uaqnkv2grl0lrjl0hdatt02s0e